使用抗癌药物是当前治疗癌症的主要手段之一,但是,现有抗癌药物对癌细胞的选择性不强,在杀伤癌细胞的同时,对正常细胞同样有杀伤作用。此外,抗癌药物的毒副反应也较大,如果使用不当,有时甚至会造成病人的死亡。那么现在有没有一种能够像导弹一样,直接命中癌细胞而又很少伤及正常细胞的抗癌药物呢?近年来,日本罗氏分公司研究和开发出一种口服的抗癌制剂氟铁龙,它具有选择性抗癌的作用。 The use of anticancer drugs is currently one of the main ways to treat cancer. However, the existing anticancer drugs are not highly selective to cancer cells and kill the cancer cells as well as kill normal cells. In addition, anti-cancer drugs are also more toxic side effects, if not used properly, and sometimes even cause the patient’s death. So now there is no one like a missile, just hit the cancer cells and rarely hurt the normal cells of anti-cancer drugs it? In recent years, Japan Roche Branch research and development of an oral anti-cancer agent, , It has a selective anti-cancer effect.